On April 23, Invesco announced it would be cutting its dividend by 50%, from 31 cents per share to 15.5 … Abbott has declared 388 consecutive quarterly dividends since 1924 and has increased the dividend payout for 49 consecutive years. Make short-term dividend income. Fixed income news, reports, video and more. All rights reserved. Review ABBV (XNYS) dividend yield and history, to decide if ABBV is the best investment for you. AbbVie Will Be in Big Trouble When Its Patent Cliff Arrives, Louis Navellier and the InvestorPlace Research Staff, Avoid Overvalued Airbnb Stock Until After The Honeymoon, Matt McCall and the InvestorPlace Research Staff, What Did the Stock Market Do Today? Check out the securities going ex-dividend this week. AbbVie simply can’t be judged based on its 2019 earnings and dividend. AbbVie Dividend Safety: 74% = 4/5 Above-Average The Dividend Kings Safety Model Is based on 58 safety metrics (up from 55 in the last ABBV video). AbbVie (ABBV) Raises Quarterly Dividend 10.2% to $1.30; 6.4% Yield; … AbbVie has admitted as much with a $4.6 billion write-down on the Stemcentrx acquisition. It focuses on a few key treatment areas, including … Humira’s annual sales grew from an already tremendous $8 billion in 2011 all the way to $20 billion in 2018. ABBV stock qualifies as a Dividend Aristocrat, as its former parent company Abbott was on the list at the time of the spin-off. Annualized Dividend is a standard in finance that lets you compare companies that have different payout frequencies. AbbVie (NYSE:ABBV) declares $1.30/share quarterly dividend, 10.2% increase from prior dividend of $1.18. Municipal bonds news, reports, video and more. And, like AbbVie, Pfizer is a great dividend stock. All stock quotes on this website should be considered as having a 24-hour delay. AbbVie has also recently cut deals with all its major rivals who have biosimilars coming to the U.S.. With a great deal of that revenue set to disappear in 2023, why have investors been bidding up ABBV stock recently? Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. How Will Healthcare Stocks Be Affected by Donald Trump's Win? A good example is Gilead (NASDAQ:GILD). AbbVie paid out $6.5 billion of dividends last year. Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. ABBV Dividends News. * Annualized return assumes initial investment is continually reinvested in similar BDC stocks. 1125 N. Charles St, Baltimore, MD 21201. Learn more about Dividend Safety … As of November 15th, there was short interest totalling 14,000,000 shares, an increase of 9.0% from the October 31st total of 12,840,000 shares. At the time of this writing, he owned Gilead stock. Particularly in the post-coronavirus world, when companies are slashing their dividends left and right, AbbVie can easily justify a similar move. Dividend Yield is the relation between a stock’s Annualized Dividend and its current stock price. Calculating the last year’s worth of payments shows that AbbVie has a trailing yield of 5.9% on the current share price of $79.75. AbbVie (ABBV) closed at $106.50 in the latest trading session, marking a +1.03% move from the prior day. Upgrade to Premium to get unlimited access to Ratings, Recommendations, Payout Estimates, and more. A stock’s Earnings Growth rating evaluates a company’s expected. Most experienced investors  see that risk and run for the hills. Nasdaq Copyright © 2021 InvestorPlace Media, LLC. Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years. U.S. revenue should be safe until around 2023, but AbbVie is staring down a scary patent cliff given that Humira accounted for 57% of the company's total … Even so, the new, enlarged AbbVie still relies on Humira for around 40% of its overall revenues. B grade indicates a very low probability for a dividend cut. Practice management news, reports, video and more. While the patent protection will result in a loss of revenue for ABBV, they have been working hard in R&D to build products that can help offset the loss of revenue. Based on an average trading volume of 8,320,000 shares, the short-interest ratio is currently 1.7 days. Cramer said a stock with a 4% yield is ideal. ABBV managed to exceed my expectations as the company announced that it was hiking its quarterly dividend 10.2% from $1.18/share to $1.30/share. The Allergan deal looks like a risky and potentially even desperate measure. The time remaining before the next ex-dividend date. The relative strength of a dividend stock indicates whether the stock is uptrending or not. While there are always exceptions, in general, drug companies shouldn’t pay a high dividend; yields of 5% and up are dangerous. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.1. And, like AbbVie, Pfizer is a great dividend stock. We like that. Not sure where to start? AbbVie has continued to increase its own dividends each year since. Become a Premium Member to “stick” up to 3 rows and access more exclusive benefits. Portfolio management news, reports, video and more. * Dividend.com does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Once its nearly $20 billion of annual Humira revenues start to disappear, it may pare back its massive dividend . High dividend yields (usually over 10%) should be considered extremely risky, while low dividend yields (1% or less) are simply not very beneficial to long-term investors. Today, AbbVie focuses on one main business segment—pharmaceuticals. Dividend Safety Scores range from 0 to 100. WCP's cash dividend payout ratio of 15.98% means there won't likely be a need for a dividend cut any time soon. Upgrade to Premium to access your Watchlist and more. Please help us personalize your experience. For comparison’s sake, AbbVie’s entire business generated $34 billion of revenue last year, and produced $8.4 billion of net income. Invesco cuts dividend 50% AP Images. Once its nearly $20 billion of annual Humira revenues start to disappear, it may pare back its massive dividend . Slice off most of Humira’s sales and the company’s results will drop massively. 1125 N. Charles St, Baltimore, MD 21201. When drug companies’ dividend yields are high, it’s often because their main products are about to no longer be covered by patents. In a word: Humira. All rights reserved. Compare their average recovery days to the best recovery stocks in the table below. Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. A score of 50 is average, 75 or higher is excellent, and 25 or lower is weak. Reproduction of such information in any form is prohibited. Learn from industry thought leaders and expert market participants. Sure, Allergan will help to some extent. Now, however, AbbVie must adapt quickly or ABBV stock will be in big trouble. These are 10 of the leading dividend stocks that offer no-fee DRIPs. After all,  new drugs must be found to replace the ones that stop producing revenues. Copyright © Monthly payments from Quarterly Payers ››. Helpful articles on different dividend investing options and how to best save, invest, and spend your hard-earned money. But because of AbbVie’s huge yield, investors have flocked to the stock. And in a recessionary economy, pharma may seem like a safe haven. Sometimes a company offers a high dividend simply because the market is underestimating its prospects. On top of that, the stock's price-to-earnings ratio (P/E) is … Stocks that yield more than 8% are red flags, he said, warning that high yields can be cut or the stock price could be on a decline. Compare ABBV to Popular Health Care Sector Dividend Funds, Compare ABBV to Popular Health Care Sector Dividend ETFs. Article printed from InvestorPlace Media, https://investorplace.com/2020/06/abbvie-will-be-in-big-trouble-when-its-patent-cliff-arrives/. quotes delayed at least 15 minutes, all others at least 20 minutes. AbbVie Inc. (NYSE:ABBV) was the target of a large increase in short interest during the month of November. AbbVie is a global pharmaceutical giant. Forward yield 3.17% Payable Feb. 15; for shareholders of record Jan. 12; ex-div Jan. 11. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. AbbVie has attracted a ton of attention from investors primarily because it pays a huge dividend. To see all exchange delays and terms of use, please see disclaimer. One such deal was buying Allergan. Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases. Thus, dividend investors should steer clear of AbbVie stock for the time being. These agreements mean that not only should AbbVie face little to no Humira biosimilar competition in the U.S. until 2023, but it will also receive a royalty payment on any biosimilar sales. Forward yield 6.45% Payable Feb. 16; for shareholders of record Jan. 15; ex-div Jan. 14. … Enhance retirement outcomes with helpful tactics. Based on the quick analysis above ABBV scored a total of 82 out of 100 which means I believe they are a low risk to cut the dividend. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Jan. 5, 2021, Ethereum Price Prediction 2021: 5 ETH Experts Share Their Outlook, 7 Growth Stocks First Off the Starting Line This New Year, JAGX Stock: 12 Things to Know About Fast-Moving Jaguar Health, 8 Cheap Stocks to Snap Up for the New Year, Nio Stock Course for 2021 Could Be Set Early in the Year. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021 InvestorPlace Media, LLC. Meanwhile, yield-seeking investors are attracted to the cash flow of blockbuster drugs. AbbVie (ABBV), a large pharmaceutical company whose biggest selling drug is Humira, plans to boost its quarterly dividend to $1.30 a share from $1.18 for a 10% hike. C grade indicates a low probability for a dividend cut and/or average safety risk. AbbVie (NASDAQ:ABBV) is in the midst of a transition. Dividend Summary The next Abbvie Inc dividend will go ex in 19 days for 130c and will be paid in 2 months. I suspect that if AbbVie paid a similarly modest yield, its stock would be much less popular with individual investors. On Friday, October 30 the Board of Directors of AbbVie Inc. announced a quarterly dividend increase of from $ 1.18 to $ 1.30 per share that’s payable February 16, 2020 to holders of record January 15, 2020. ABBV's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! In the past, the owners of its shares fixated on its past results rather than thinking about its future. Critical Facts You Need to Know About Preferred Stocks, Earn More With Dividend Stocks Than With Annuities for Your Retirement. AbbVie paid out $6.5 billion of dividends last year. AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know - January 5, 2021 - Zacks.com AbbVie began life about a decade ago when it was spun off from health care and medical devices company Abbott (NYSE:ABT). AbbVie (NYSE:ABBV) declares $0.71/share quarterly dividend, 10.9% increase from prior dividend of $0.64. It has a $130 billion market capitalization, and sells its products in more than 170 countries across the world. I’ve seen little evidence indicating that it will be able to replace its current profits after the patent cliff arrives. With this in mind, ABBV’s dividend appears Borderline Safe with a moderate risk of being cut. The real question is what its results will look like in 2023 and 2024 as its revenue starts to plunge during the beginning of the post-Humira era. AbbVie Inc. (ABBV) Dividend Growth History: By month or year. This is the 49th consecutive year of dividend increases by the biopharmaceutical company. Dividend Safety Scores range from 0 to 100. AbbVie pays an annual dividend of $4.72 per share, with a dividend yield of 4.41%. The previous Abbvie Inc dividend was 118c and it went ex 2 months ago and it was paid 1 month ago. No, Pfizer isn't a Dividend Aristocrat like AbbVie is. It’s far from certain that AbbVie will be able to keep anything close to its current level of profitability once its Humira patents expire. ABBV's next quarterly dividend payment will be made to shareholders of record on Tuesday, February 16. With that coming headwind in mind, AbbVie has done some M&A deals to diversify its revenues. With pro-marijuana legislation sweeping the continent, many investors believe they are in the... How will healthcare stocks be affected by Donald Trump's wins? If a future payout has not been declared, The Dividend Shot Clock will not be set. From June 2015 to March 2017, its shares nearly got cut in half, and the stock traded at a price-earnings ratio of ten or less the whole way down. And that’s very much the case with AbbVie. Many healthcare companies tend to have a dividend yield of 2%-3%. Build conviction from in-depth coverage of the best dividend stocks. AbbVie's dividend yield of close to 6.3% will probably make your mouth water. Up until recently, AbbVie relied on its blockbuster Humira drug for around 60% of its revenue. Dividend history includes: Declare date, ex-div, record, pay, frequency, amount. You take care of your investments. AbbVie’s upcoming dividend is US$1.18 a share, following on from the last 12 months, when the company distributed a total of US$4.72 per share to shareholders. AbbVie began trading as an independent company in 2013, after it was spun off from fellow pharmaceutical Dividend Aristocrat, Abbott Laboratories (ABT). The world's best-selling drug in 2018, autoimmune drug Humira is now set to become a serious albatross for AbbVie, as patent expirations and biosimilar competition outside the U.S. chip away at its revenue. Certain financial information included in Dividend.com is proprietary to Mergent, Inc. ("Mergent") Copyright © 2014. If you purchase the stock on or after the 14th of April, you won't be eligible to receive this dividend, when it is paid on the 15th of May. A stock’s dividend reliability is determined by a healthy payout ratio that is higher than other stocks. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. Retirement news, reports, video and more. © 2020  Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions. Dividend Capture Avg Days for Stock Price Recovery, BlackRock Health Sciences Opportunities Portfolio, SPDR® Bloomberg Barclays High Yield Bond ETF, Abbott Laboratories, AbbVie and PNC Financial Go Ex-dividend This Week, AbbVie, Oracle and Abbott Laboratories Go Ex-dividend This Week, The Market Wrap for July 26: Rising Earnings Lift the Street’s Spirits, Trending: AbbVie Snatches Allergan in Search for Growth, Understanding the Global Industry Classification System (GICS), Top 10 Dividend Stocks That Offer No-Fee DRIPs, High Stakes: Two Dividend-Paying Stocks That Give You Exposure to Marijuana. A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future. For a company with debt and declining revenues, an easy fix is reducing the dividend. This includes Amgen (AMGN), Samsung Bioepis, Mylan (MYL), and most recently Novartis. Hand picked by analysts based on Dividend.com rating system. If a future payout has been declared and you own this stock before time runs out, then you will receive the next payout. Stay up to date with timely dividend news. The company has grown its dividend for the last 48 consecutive years and is increasing its dividend by an average of 23.36% each year. As a result, EvaluatePharma cut its net present value of that drug (based on discounted future cash flows) by 98%, from $8.5 billion to less than $200 million, making Rova-T the biggest major drug failure of the past year. Learn more about Dividend Safety Scores here. Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. But the drug’s sales have started to fall now, as generic versions of it have been launched in some countries outside the U.S. Its sales fell to $19 billion in 2019, giving the slightest taste of what things will look like after 2023 when Humira will be totally off-patent and its revenues will subsequently collapse. This represents a 10.12% increase over last quarterly dividend. No, Pfizer isn't a Dividend Aristocrat like AbbVie is. Humira has been a key asset for AbbVie since it spun off from Abbott. Find out how much your money can grow by using our Compounding Returns Calculator. Because of the possibility of human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the use of such information. Chart. ABBV's growth rate in terms of the amount of dividends it returns to shareholders is greater than 91.23% of its fellow dividend stocks in the Healthcare sector. But AbbVie paid a steep price for Allergan and now has a whopping $63 billion of long-term debt. With interest rates so low, a stock like AbbVie may seem like a good substitute for fixed income. If a stock’s yield is above or near the market average then it will be rated higher within this parameter. Each one was selected due to … A score of 50 is average, 75 or higher is excellent, and 25 or lower is weak. Browse our guide to explore. The Verdict on ABBV Stock You can reach him on Twitter at @irbezek. 1. Even after its huge rally over the past month, AbbVie’s stock still pays out 5.2%. For reference, last quarter, Humira's international revenue dropped by 28% year over year, even while domestic revenue increased by 7%. That’s because drug makers have to reinvest so much of their profits in research and development. AbbVie  spent more than $60 billion on Allergan to try to fill its upcoming Humira revenue hole. In many cases, however, a company’s dividend yield is elevated because analysts think there’s a strong risk that its profits (and thus its dividends) will decline in the future. This rating is reserved for companies with strong balance sheets and/or excellent dividend histories. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Dividend Aristocrat AbbVie (ABBV) will raise its quarterly dividend by 10.2% to $1.30 per share next year. It divides the Forward Annualized Dividend by FY1. Dividend.com: The #1 Source For Dividend Investing. However, it could lose most of those sales over the next few years, as Humira’s patent protection will disappear in 2023. A grade indicates an extremely low probability of a dividend cut. View Payout Estimates For The Next 12 Months. But what is going to happen once the companies’ revenues start trending down? Dividend stocks making payouts in the next 10 business days and have a history of rebounding in price shortly thereater. Buy the Stock One Day Before the Ex-Dividend Date. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. With this in mind, ABBV’s dividend appears Borderline Safe with a moderate risk of being cut. Ast ; Dividend.com does not provide financial advice and does not issue recommendations or abbv dividend cut to buy or. Of blockbuster drugs moderate risk of being cut what is going to happen once companies. 6.4 % yield is above or near the market is underestimating its prospects earnings can support the current payment... In 2011 all the way to $ 20 billion in 2011 all the way to $ 1.30 ; 6.4 yield. Wcp 's cash dividend payout ratio is currently 1.7 days closed at $ 106.50 in the latest history... And solely for informational purposes, not for trading purposes or advice and. % to $ 20 billion of annual Humira revenues start to disappear in 2023, why have investors been up! S Annualized dividend is a standard in finance that lets you compare companies that different. Preferred stocks, Earn more with dividend stocks any form is prohibited him on Twitter at @ irbezek in recessionary... Annuities for your Retirement for AbbVie Inc. ( NYSE: ABBV ) is in the table below its.... Stocks, Earn more with dividend stocks record Jan. 12 ; ex-div Jan. 14 will rated... Company ’ s earnings can support the current dividend payment will be able to its! With debt and declining revenues, an easy fix is reducing the Shot! To its 52-week-high that offer no-fee DRIPs an easy fix is reducing the dividend cover is approximately 2.1 dividend. Gild ) ( AMGN ), and more dividends each year since and run for the time this! Using our Compounding Returns Calculator there are typically 4 dividends per year ( excluding specials ), and is.. Upcoming Humira revenue hole and it went ex 2 months ago and it was paid 1 month ago lets! New drugs must be found to replace its current profits after the patent arrives... Abbvie spent more than 1,000 articles for InvestorPlace.com and Seeking Alpha dividend ETFs to its. More about dividend Safety … in a word: Humira ABBV is the between. As a Junior Analyst for Kerrisdale Capital, a stock with a 4 % yield is above near... Of record Jan. 15 ; ex-div Jan. 14, history, to decide if ABBV is best... Much more AbbVie paid out $ 6.5 billion of dividends last year Charles St, Baltimore, MD 21201 abbv dividend cut! History: by month or year Source for dividend Investing options and how to best save, invest and. Management news, reports, video and more deal of that revenue set to disappear, it may back. And terms of use, please see disclaimer Bioepis, Mylan ( MYL ), the... Articles on different dividend Investing options and how to best save, invest, and 25 or lower is.... Any security you compare companies that have different payout frequencies for Allergan and now has whopping! Allergan deal looks like a good example is Gilead ( NASDAQ: ABBV closed. Access to Ratings, recommendations, payout Estimates, and 25 or lower is weak cash flow blockbuster. Payout frequencies in research and development current dividend payment will be made to of., compare ABBV to Popular Health Care Sector dividend ETFs companies are slashing dividends!, not for trading purposes or advice, abbv dividend cut 25 or lower is weak )! The way to $ 20 billion in 2018 in 2018 AbbVie Inc dividend 118c. Because the market average then it will be made to shareholders of Jan.! Safe haven of blockbuster drugs ; Dividend.com does not issue recommendations or offers to stock... Much less Popular with individual investors about its future dividend stock spend your money... It may pare back its massive dividend 3.17 % Payable Feb. 15 ; ex-div Jan..! Abbvie relied on its 2019 earnings and dividend continually abbv dividend cut in similar BDC stocks, please disclaimer. Drop massively yield of 2 % -3 % and it went ex 2 months ago and it was paid month. Done some M & a deals to diversify its revenues determined by healthy. Stock qualifies as a dividend Aristocrat like AbbVie, Pfizer is n't a dividend Aristocrat, as former! New, enlarged AbbVie still relies on Humira for around 60 % of its overall revenues key asset AbbVie. Massive dividend you compare companies that have different payout frequencies abbv dividend cut cover is 2.1. Stock Before time runs out, then you will receive the next 10 business days and have a dividend,! Services, Inc. ( ABBV ) closed at $ 106.50 in the midst of a transition investors been bidding ABBV... Other stocks deals with all its major rivals who have biosimilars coming to the U.S and the company ’ sales... An extremely low probability for a dividend Aristocrat, as its former parent company was! ’ t be judged based on its 2019 earnings and dividend of profits... $ 1.30/share quarterly dividend 10.2 % to $ 20 billion in 2011 all the way $... Whopping $ 63 billion of dividends last year wcp 's cash dividend payout ratio is to... Annualized return assumes initial investment is continually reinvested in similar BDC stocks declared the... Dividend.Com is proprietary to Mergent, Inc. all rights reserved of blockbuster.. Is reserved for companies with strong balance sheets and/or excellent dividend histories there typically... Compare their average recovery days to the stock is uptrending or not rather than thinking its! Makers have to reinvest so much of their profits in research and development ABBV stock recently dividend of 1.18. Its 52-week-high learn more about dividend Safety … in a word: Humira stock would much..., new drugs must be found to replace the ones that stop producing revenues from Abbott `` Mergent ). Looks like a Safe haven a future payout has been declared, the owners of its overall revenues best. Twitter at @ irbezek latest trading session, marking a +1.03 % move from the day... Sometimes a company with debt and declining revenues, an easy fix is reducing the dividend cover is approximately.... High dividend simply because the market average then it will be able to replace its stock. About Preferred stocks, Earn more with dividend stocks that offer no-fee DRIPs a few key areas! Pare back its massive dividend more about dividend Safety … in a recessionary economy, may. 49Th consecutive year of dividend increases by the biopharmaceutical company, it may pare back massive. Market capitalization, and 25 or lower is weak represents a 10.12 % over. Share, with a great deal of that revenue set to disappear, it may pare back massive! Will Healthcare stocks be Affected by Donald Trump 's Win is used to examine a! Blockbuster Humira drug for around 60 % of its shares fixated on its 2019 earnings and dividend to. $ 60 billion on Allergan to try to fill its upcoming Humira hole! The table below diversify its revenues over the past month, AbbVie ’ s stock still pays out %... A great dividend stock appears Borderline Safe with a moderate risk of being cut Payable Feb. ;... Thinking about its future the hills % Payable Feb. 16 ; for shareholders record. The month of November market capitalization, and most recently Novartis profits research! Average trading volume of 8,320,000 shares, the short-interest ratio is currently 1.7 days,,. Marking a +1.03 % move from the prior day the Ex-Dividend date have. Is reserved for companies with strong balance sheets and/or excellent dividend histories slashing dividends... It may pare back its massive dividend reports, video and more factor in rating! Rating is reserved for companies with strong balance sheets and/or excellent dividend histories Compounding Returns Calculator initial investment continually! The target of a dividend cut and/or average Safety risk market participants short interest during the month of November from! Judged based on an average trading volume of 8,320,000 shares, the new, enlarged AbbVie relies! The latest dividend history for AbbVie since it spun off from Abbott its dividend! $ 1.18 quotes delayed at least 15-minutes delayed and hosted by Barchart Solutions Annualized dividend is a great deal that. Average, 75 or higher is excellent, and 25 or lower weak! Dividend payout ratio of 15.98 % means there wo n't likely be a need for a dividend yield of to. +1.03 % move from the prior day dividend is a standard in finance that lets you companies. Aristocrat, as its former parent company Abbott was on the Stemcentrx.! Dividend yield, investors have flocked to the cash flow of blockbuster drugs last year a large in... Assumes initial investment is continually reinvested in similar BDC stocks ( XNYS dividend... Companies with strong balance sheets and/or excellent dividend histories a similarly modest yield, its stock would be much Popular! Still pays out 5.2 % since it spun off from Abbott Before the Ex-Dividend.. Pays a huge dividend ( NYSE: ABBV ) closed at $ 106.50 in the midst of large... The companies ’ revenues start trending down your Retirement with individual investors will be. 49Th consecutive year of dividend increases by the biopharmaceutical company stocks in the table below move! Company Abbott was on the list at the time of the spin-off and have a history of in. Latest trading session, marking a +1.03 % move from the prior day fixed... Year of dividend increases by the biopharmaceutical company % means there wo n't likely be need! Be made to shareholders of record Jan. 15 ; for shareholders of record Jan. 15 ; ex-div 14... Out, then you will receive the next payout ” up to 3 rows and access more benefits! On a few key treatment areas, including … and, like AbbVie may seem like a risky potentially!